These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3923865)

  • 1. Long-term, pulsatile, low dose, subcutaneous luteinizing hormone-releasing hormone administration in men with idiopathic oligozoospermia. Failure of therapeutic and hormonal response.
    Fauser BC; Rolland R; Dony JM; Corbey RS
    Andrologia; 1985; 17(2):143-9. PubMed ID: 3923865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased frequency of pulsatile luteinizing hormone-releasing hormone administration selectively decreases follicle-stimulating hormone levels in men with idiopathic azoospermia.
    Gross KM; Matsumoto AM; Berger RE; Bremner WJ
    Fertil Steril; 1986 Mar; 45(3):392-6. PubMed ID: 3081382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum luteinizing hormone-releasing hormone (LH-RH) and gonadotropic hormones in men after a bolus dose of LH-RH: comparison of different doses and routes of administration.
    Fauser BC; Rolland R; Thomas CM; Doesburg WH; Dony JM
    Fertil Steril; 1985 Sep; 44(3):384-9. PubMed ID: 3928407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-Tryptophan-6-luteinizing hormone-releasing hormone in the treatment of normogonadotropic oligoasthenozoospermia.
    Schwarzstein L; Aparicio NJ; Schally AV
    Int J Androl; 1982 Apr; 5(2):171-8. PubMed ID: 6213567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of luteinizing hormone and follicle-stimulating hormone to different doses of D-leucine-6-LH-RH ethylamide in oligospermic patients.
    Turner D; Turner EA; Aparicio NJ; Schwarzstein L; Coy DH; Schally AV
    Fertil Steril; 1976 May; 27(5):545-8. PubMed ID: 776707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary gonadotropin responses to different modes and doses of intravenous luteinizing hormone-releasing hormone administration in normal men.
    Fauser BC; Rolland R; Dony JM; Doesburg WH; Thomas CM
    Fertil Steril; 1984 May; 41(5):748-53. PubMed ID: 6425088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of clomiphene citrate on plasma levels of immunoreactive luteinizing hormone-releasing hormone, gonadotropin, and testosterone in normal subjects and in patients with idiopathic oligospermia.
    Masala A; Delitala G; Alagna S; Devilla L; Lotti G
    Fertil Steril; 1978 Apr; 29(4):424-7. PubMed ID: 348501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pituitary-testicular response to luteinising hormone releasing hormone administration to normal men.
    de Kretser DM; Burger HG; Hudson B; Keogh
    Aust N Z J Med; 1975 Jun; 5(3):227-30. PubMed ID: 1100030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hormonal response of patients with polycystic ovarian disease to subcutaneous low frequency pulsatile administration of luteinizing hormone-releasing hormone.
    Hurwitz A; Rosenn B; Palti Z; Ebstein B; Har-Nir R; Ron M
    Fertil Steril; 1986 Sep; 46(3):378-84. PubMed ID: 2943606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM; Gow SM; Wu FC
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin and steroid secretory patterns during chronic treatment with a luteinizing hormone-releasing hormone agonist analog in men.
    Evans RM; Doelle GC; Alexander AN; Uderman HD; Rabin D
    J Clin Endocrinol Metab; 1984 May; 58(5):862-7. PubMed ID: 6423661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.
    Matsumoto AM
    J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
    Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective reduction of elevated FSH levels in infertile men by pulsatile LHRH treatment.
    Hönigl W; Knuth UA; Nieschlag E
    Clin Endocrinol (Oxf); 1986 Feb; 24(2):177-82. PubMed ID: 3085994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testicular steroid response to continuous and pulsatile intravenous luteinizing hormone-releasing hormone administration in normal men.
    Fauser BC; Smals AG; Rolland R; Dony JM; Doesburg WH; Thomas CM
    Andrologia; 1986; 18(1):89-96. PubMed ID: 3082245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered pulsatile pattern of luteinizing hormone in men with idiopathic normogonadotropic oligospermia.
    Levalle OA; Aszenmil G; Espínola B; Romo A; Polak E; Del Pozo E; Guitelman A
    Fertil Steril; 1988 Aug; 50(2):337-42. PubMed ID: 3135207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulsatile LH-RH treatment induces a relatively low response of LH and FSH, while discontinuation enhances the response in women with amenorrhea of suprapituitary origin.
    Lambalk CB; Schoemaker J; van Rees GP; van Dieten JA
    Gynecol Endocrinol; 1988 Sep; 2(3):183-93. PubMed ID: 3147582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prolonged treatment with LH-RH of 6 men with oligoasthenozoospermia and normogonadotropic idiopathic azoospermia].
    Póvoa LC; Dos Santos RR; Schermann J; Comarú Schally AM; Schally AV
    Reproduccion; 1982; 6(3-4):151-8. PubMed ID: 6818054
    [No Abstract]   [Full Text] [Related]  

  • 19. Initiation of gonadotropin responsiveness in hypothalamic hypogonadism: comparison of pulsatile and continuous nocturnal subcutaneous administration of LH-RH.
    Vierhapper H; Waldhäusl W
    Exp Clin Endocrinol; 1983 May; 81(3):249-54. PubMed ID: 6411482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The frequency of pulsatile luteinizing hormone-releasing hormone treatment and luteinizing hormone and follicle-stimulating hormone secretion in women with amenorrhea of suprapituitary origin.
    Lambalk CB; Schoemaker J; van Rees GP; van Dieten HA
    Fertil Steril; 1989 Mar; 51(3):416-22. PubMed ID: 2493401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.